Neuland Laboratories Ret. on equity
What is the Ret. on equity of Neuland Laboratories?
The Ret. on equity of Neuland Laboratories Limited is 3.61%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on BSE compared to Neuland Laboratories
What does Neuland Laboratories do?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Companies with ret. on equity similar to Neuland Laboratories
- Agree Realty has Ret. on equity of 3.60%
- Suzhou HYC Technology Co has Ret. on equity of 3.60%
- Dynamatic Technologies has Ret. on equity of 3.60%
- Asta Funding has Ret. on equity of 3.61%
- Saga Communications has Ret. on equity of 3.61%
- Mobius Investment Trust Plc has Ret. on equity of 3.61%
- Neuland Laboratories has Ret. on equity of 3.61%
- Jyoti has Ret. on equity of 3.62%
- Carclo plc has Ret. on equity of 3.62%
- Sequent Scientific has Ret. on equity of 3.62%
- Xinjiang GoldWind Science & Technology Co has Ret. on equity of 3.62%
- Bigben Interactive SA has Ret. on equity of 3.63%
- China Resources Medical has Ret. on equity of 3.63%